Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kinematic vs Clinical Assessment for Botox in Cervical Dystonia
NCT02662530Phase 2Unknown
- Sponsor
- Western University
- Start
- Jan 2012
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of botulinum toxin type A in cervical dystonia (CD) (2 arms), sponsored by Western University. Primary endpoints: Toronto Western Spasmodic Torticollis Rating Scale Part A and C at 30 weeks and Objective Kinematic Reductions in Angular Deviation and Amplitude at 30 weeks. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT02662530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02662530.